Denali Therapeutics Inc. / Financial strength (Piotroski F-Value) /

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    You are viewing the F-Value as of . Click to view the current F-Value instead.

    Financial strength (Piotroski F-Value)
    4 / 9
    Return on assets (ROA) greater than 0
    close -8.7%
    Operating cash flow greater than 0
    close -$352.11M
    ROA greater than previous year
    check -8.7% > -26.3%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    close -26.1% ≤ -8.7%
    Leverage ratio lower than previous year
    check 2.7% < 3.6%
    Current ratio greater than previous year
    check 1,178.9% > 338.8%
    No new common stock issued last year
    close $439.67M
    Gross margin greater than previous year
    check 182.0% > 85.3%
    Asset turnover greater than previous year
    close -0.6% ≤ 7.2%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    3
    1
    3
    3
    4
    3
    3
    3
    2
    3
    2
    2
    8
    8
    8
    8
    1
    1
    1
    2
    5
    5
    5
    4
    2
    4
    3
    3
    2
    3
    3

    Notifications